Reduction of endotoxicity in Bordetella bronchiseptica by lipid A engineering: Characterization of lpxL1 and pagP mutants
Open Access
- 31 May 2021
- journal article
- research article
- Published by Taylor & Francis in Virulence
- Vol. 12 (1) , 1452-1468
Abstract
Whole-cell vaccines against Gram-negative bacteria commonly display high reactogenicity caused by the endotoxic activity of lipopolysaccharide (LPS), one of the major components of the bacterial outer membrane. Underacylation of the lipid A moiety of LPS has been related with reduced endotoxicity in several Gram-negative species. Here, we evaluated whether the inactivation of two genes encoding lipid A acylases of Bordetella bronchiseptica, i.e. pagP and lpxL1, could be used for the development of less reactogenic vaccines against this pathogen for livestock and companion animals. Inactivation of pagP resulted in the loss of the secondary palmitate chain at position 3' of lipid A, but hardly affected the potency of the LPS to activate the Toll-like receptor 4 (TLR4). Inactivation of lpxL1 resulted in the loss of the secondary 2-hydroxy laurate group present at position 2 of lipid A and, unexpectedly, in the additional loss of the glucosamines that decorate the phosphate groups at positions 1 and 4' and in an increase in LPS molecules carrying O-antigen. The resulting LPS showed greatly reduced potency to activate TLR4 in HEK-Blue reporter cells expressing human or mouse TLR4 as well as in porcine macrophages. Characterization of the lpxL1 mutant revealed many pleiotropic phenotypes, including increased resistance to SDS and rifampicin, increased susceptibility to cationic antimicrobial peptides, decreased auto-aggregation and biofilm formation, and a tendency to decreased infectivity of macrophages, which are all related to the altered LPS structure. We suggest that the lpxL1 mutant will be useful for the generation of safer vaccines.Keywords
Funding Information
- TTW Perspective (14, 921 and 14, 924)
This publication has 55 references indexed in Scilit:
- Structural Modifications of Bacterial Lipopolysaccharide that Facilitate Gram-Negative Bacteria Evasion of Host Innate ImmunityFrontiers in Immunology, 2013
- Role of pagL and lpxO in Bordetella bronchiseptica Lipid A BiosynthesisJournal of Bacteriology, 2011
- Substitution of the Bordetella pertussis Lipid A Phosphate Groups with Glucosamine Is Required for Robust NF-κB Activation and Release of Proinflammatory Cytokines in Cells Expressing Human but Not Murine Toll-Like Receptor 4-MD-2-CD14Infection and Immunity, 2010
- Identification of a Novel Lipopolysaccharide Core Biosynthesis Gene Cluster in Bordetella pertussis , and Influence of Core Structure and Lipid A Glucosamine Substitution on Endotoxic ActivityInfection and Immunity, 2009
- Bacterial Adhesins in Host-Microbe InteractionsCell Host & Microbe, 2009
- Glucosamine Found as a Substituent of Both Phosphate Groups inBordetellaLipid A Backbones: Role of a BvgAS-Activated ArnT OrthologJournal of Bacteriology, 2008
- Comparative Role of Immunoglobulin A in Protective Immunity against the BordetellaeInfection and Immunity, 2007
- Lipid A Modification Systems in Gram-Negative BacteriaAnnual Review of Biochemistry, 2007
- Expression of the Lipopolysaccharide-Modifying Enzymes PagP and PagL Modulates the Endotoxic Activity ofBordetella pertussisInfection and Immunity, 2006
- Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due toBordetella pertussisand OtherBordetellaSubspeciesClinical Microbiology Reviews, 2005